Novel type 2 oral polio vaccine secures WHO prequalification for broader rollout

The novel type 2 oral polio vaccine (nOPV2), developed by a team including scientists from the Medicines and Healthcare products Regulatory Agency (MHRA), has today (9 January) been quality-assured (prequalified) by the World Health Organization (WHO).

ATOMIC-Meso Trial: A New Take Against Pleural Mesothelioma

Jonathan Sharp, CFO at Environmental Litigation Group, P.C. Pleural mesothelioma is a type of an aggressive cancer that develops in the tissue that surrounds the

January 23, 2025

What the 2024 election looks like from the therapist’s room

I am standing in front of my bathroom mirror trying to control my breathing. It is the morning after the election, and I learned the

November 8, 2024

Study links ultra-processed foods to gut health risks

A review in Nature Reviews Gastroenterology & Hepatology synthesizes evidence on the negative impacts of ultra-processed foods and food additives on gut health, linking them

February 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.